Please login to the form below

Not currently logged in


This page shows the latest Lenvima news and features for those working in and with pharma, biotech and healthcare.

Eisai’s Lenvima wins European liver cancer indication

Eisai’s Lenvima wins European liver cancer indication

Lenvima however, is already on the European market to treat thyroid cancer, but thanks to positive data from the phase III REFLECT study, Eisai can now add another string to the ... Additionally, Lenvima also demonstrated statistically significant

Latest news

More from news
Approximately 9 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...